Publicaciones en colaboración con investigadores/as de University of British Columbia (5)

2023

  1. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

    ESMO Open, Vol. 8, Núm. 3

2015

  1. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): Overall survival results of a phase 3 randomised trial

    The Lancet Oncology, Vol. 16, Núm. 8, pp. 928-936

2013

  1. Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: Quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

    The Lancet Oncology, Vol. 14, Núm. 3, pp. 236-243

2011

  1. A phase 3 trial of bevacizumab in ovarian cancer

    New England Journal of Medicine, Vol. 365, Núm. 26, pp. 2484-2496

2010

  1. Advanced ovarian cancer: Phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel

    Journal of the National Cancer Institute, Vol. 102, Núm. 20, pp. 1547-1556